Reed Smith LLP

Food and Drug Law Journal

Considering Modifications to Existing Regulatory Incentives to Achieve Greater Racial and Ethnic Diversity in Pivotal Clinical Trials for Drug Approvals

Subscribe
Inicio Perspectivas Considering Modifications to Existing Regulatory Incentives to Achieve Greater Racial and Ethnic Diversity in Pivotal Clinical Trials for Drug Approvals

Autores: Sarah Thompson Schick Kirsten Axelsen